We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth Group (UNH) Advances While Market Declines: Some Information for Investors
Read MoreHide Full Article
In the latest close session, UnitedHealth Group (UNH - Free Report) was up +1.3% at $331.83. This change outpaced the S&P 500's 0.03% loss on the day. Meanwhile, the Dow experienced a drop of 0.04%, and the technology-dominated Nasdaq saw a decrease of 0.09%.
The largest U.S. health insurer's stock has dropped by 0.65% in the past month, falling short of the Medical sector's loss of 0.5% and the S&P 500's gain of 2.57%.
The upcoming earnings release of UnitedHealth Group will be of great interest to investors. The company's earnings report is expected on January 27, 2026. In that report, analysts expect UnitedHealth Group to post earnings of $2.09 per share. This would mark a year-over-year decline of 69.31%. Alongside, our most recent consensus estimate is anticipating revenue of $113.64 billion, indicating a 12.73% upward movement from the same quarter last year.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $16.3 per share and revenue of $448.03 billion, indicating changes of -41.07% and +11.93%, respectively, compared to the previous year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for UnitedHealth Group. These recent revisions tend to reflect the evolving nature of short-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. UnitedHealth Group presently features a Zacks Rank of #3 (Hold).
In the context of valuation, UnitedHealth Group is at present trading with a Forward P/E ratio of 20.09. This denotes a premium relative to the industry average Forward P/E of 13.62.
Meanwhile, UNH's PEG ratio is currently 2.13. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The average PEG ratio for the Medical - HMOs industry stood at 1.33 at the close of the market yesterday.
The Medical - HMOs industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 204, positioning it in the bottom 18% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
UnitedHealth Group (UNH) Advances While Market Declines: Some Information for Investors
In the latest close session, UnitedHealth Group (UNH - Free Report) was up +1.3% at $331.83. This change outpaced the S&P 500's 0.03% loss on the day. Meanwhile, the Dow experienced a drop of 0.04%, and the technology-dominated Nasdaq saw a decrease of 0.09%.
The largest U.S. health insurer's stock has dropped by 0.65% in the past month, falling short of the Medical sector's loss of 0.5% and the S&P 500's gain of 2.57%.
The upcoming earnings release of UnitedHealth Group will be of great interest to investors. The company's earnings report is expected on January 27, 2026. In that report, analysts expect UnitedHealth Group to post earnings of $2.09 per share. This would mark a year-over-year decline of 69.31%. Alongside, our most recent consensus estimate is anticipating revenue of $113.64 billion, indicating a 12.73% upward movement from the same quarter last year.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $16.3 per share and revenue of $448.03 billion, indicating changes of -41.07% and +11.93%, respectively, compared to the previous year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for UnitedHealth Group. These recent revisions tend to reflect the evolving nature of short-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. UnitedHealth Group presently features a Zacks Rank of #3 (Hold).
In the context of valuation, UnitedHealth Group is at present trading with a Forward P/E ratio of 20.09. This denotes a premium relative to the industry average Forward P/E of 13.62.
Meanwhile, UNH's PEG ratio is currently 2.13. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The average PEG ratio for the Medical - HMOs industry stood at 1.33 at the close of the market yesterday.
The Medical - HMOs industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 204, positioning it in the bottom 18% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.